Guerrilla RF (GUER) 10-Q 14 Nov 24 2024 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2024	Nov. 07, 2024
Document Information [Line Items]
Entity Central Index Key	0001832487
Entity Registrant Name	Guerrilla RF, Inc.
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	000-56238
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-3837067
Entity Address, Address Line One	2000 Pisgah Church Road
Entity Address, City or Town	Greensboro
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	27455
City Area Code	336
Local Phone Number	510-7840
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		10,219,930

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Assets
Cash	$ 11,277,741	$ 781,318
Accounts receivable, net	1,822,514	2,079,111
Inventories, net	1,916,510	1,533,592
Prepaid expenses	214,027	458,313
Total Current Assets	15,230,792	4,852,334
Prepaid expenses and other	78,751	0
Intangible assets, net	355,829	0
Operating lease right-of-use assets	9,627,914	10,500,620
Property, plant, and equipment, net	2,869,845	3,659,084
Total Assets	28,163,131	19,012,038
Liabilities, Redeemable Preferred Stock and Stockholders' Deficit
Accounts payable and accrued expenses	2,004,855	2,099,537
Short-term debt	855,305	1,628,667
Derivative liabilities	0	158,000
Warrant liabilities	6,946,522	0
Operating lease liability, current portion	657,978	745,969
Finance lease liability, current portion	800,091	978,543
Notes payable, current portion, net	0	10,948,668
Total Current Liabilities	11,264,751	17,338,478
Long-term debt	493,214	698,600
Operating lease liability	5,694,467	6,176,508
Finance lease liability	1,045,966	1,593,979
Notes payable	4,500,000	0
Total Liabilities	22,998,398	25,807,565
Commitments and Contingencies
Stockholders' Deficit
Undesignated preferred stock, $0.0001 par value, 9,978,000 shares authorized, no shares issued and outstanding as of September 30, 2024 and December 31, 2023	0	0
Common stock, $0.0001 par value, 50,000,000 shares authorized, 10,206,931 and 7,893,205 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	1,021	789
Additional paid-in capital	40,500,327	36,243,146
Accumulated deficit	(55,370,170)	(43,039,462)
Total Stockholders' Deficit	(14,868,822)	(6,795,527)
Total Liabilities, Redeemable Preferred Stock and Stockholders' Deficit	28,163,131	19,012,038
Series A Convertible Preferred Stock [Member]
Liabilities, Redeemable Preferred Stock and Stockholders' Deficit
Series A convertible preferred stock, $0.0001 par value, 22,000 shares authorized, 22,000 and 0 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	20,033,555	0
Nonrelated Party [Member]
Liabilities, Redeemable Preferred Stock and Stockholders' Deficit
Convertible notes	0	78,905
Related Party [Member]
Liabilities, Redeemable Preferred Stock and Stockholders' Deficit
Convertible notes	$ 0	$ 700,189

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Sep. 30, 2024	Dec. 31, 2023
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	9,978,000	9,978,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	50,000,000	50,000,000
Common stock, issued (in shares)	10,206,931	7,893,205
Common stock, outstanding (in shares)	10,206,931	7,893,205
Series A Convertible Preferred Stock [Member]
Temporary Equity, Par or Stated Value Per Share (in dollars per share)	$ 0.0001	$ 0.0001
Temporary Equity, Shares Authorized (in shares)	22,000	22,000
Temporary Equity, Shares Issued (in shares)	22,000	0
Temporary Equity, Shares Outstanding (in shares)	22,000	0
Preferred stock, shares issued (in shares)	22,000	0
Preferred stock, shares outstanding (in shares)	22,000	0

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues	$ 4,523,700	$ 3,365,911	$ 15,725,503	$ 10,376,133
Direct product costs	1,571,182	1,490,779	5,562,138	4,444,005
Gross Profit	2,952,518	1,875,132	10,163,365	5,932,128
Operating Expenses:
Research and development	2,506,554	2,775,430	7,170,628	8,014,588
Sales and marketing	1,749,497	1,445,790	4,685,783	4,437,683
General and administrative	1,306,268	1,381,119	3,951,953	4,304,624
Total Operating Expenses	5,562,319	5,602,339	15,808,364	16,756,895
Operating Loss	(2,609,801)	(3,727,207)	(5,644,999)	(10,824,767)
Interest income	63,873	0	63,873	0
Interest expense	(501,163)	(731,618)	(3,042,418)	(1,462,487)
Loss on debt extinguishment	(1,523,221)	0	(1,523,221)	0
Change in fair value of warrant liabilities	(2,623,608)	0	(2,623,608)	0
Change in fair value of derivative liabilities	0	(47,400)	158,000	(47,400)
Other income (expense)	(7,645)	25,277	281,665	31,206
Total Other Expenses, net	(4,591,764)	(753,741)	(6,685,709)	(1,478,681)
Net Loss	$ (7,201,565)	$ (4,480,948)	$ (12,330,708)	$ (12,303,448)
Net loss per share - basic and diluted (in dollars per share)	$ (0.71)	$ (0.62)	$ (1.31)	$ (1.8)
Weighted average common shares outstanding - basic and diluted (in shares)	10,139,230	7,211,095	9,392,326	6,841,253
Product [Member]
Revenues	$ 4,523,620	$ 3,354,879	$ 15,723,125	$ 9,970,600
Royalty and Non-recurring Engineering [Member]
Revenues	$ 80	$ 11,032	$ 2,378	$ 405,533

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2022	$ 621	$ 29,427,440	$ (27,073,168)	$ 2,354,893
Net loss	0	0	(4,001,418)	(4,001,418)
Equity financing, net of issuance costs	53	3,658,622	0	3,658,675
Share-based compensation	3	268,637	0	268,640
Balance at Mar. 31, 2023	678	33,454,698	(31,074,586)	2,380,790
Shares issued for prepaid services	1	99,999	0	100,000
Share-based compensation	3	268,637	0	268,640
Balance at Dec. 31, 2022	621	29,427,440	(27,073,168)	2,354,893
Net loss				(12,303,448)
Reclassification of historical warrants				0
Balance at Sep. 30, 2023	789	35,851,380	(39,376,616)	(3,524,447)
Balance at Mar. 31, 2023	678	33,454,698	(31,074,586)	2,380,790
Net loss	0	0	(3,821,082)	(3,821,082)
Equity financing, net of issuance costs	1	96,756	0	96,757
Share-based compensation	0	330,177	0	330,177
Balance at Jun. 30, 2023	679	33,881,631	(34,895,668)	(1,013,358)
Share-based compensation	0	330,177	0	330,177
Net loss	0	0	(4,480,948)	(4,480,948)
Equity financing, net of issuance costs	106	1,685,120	0	1,685,226
Share-based compensation	4	284,629	0	284,633
Balance at Sep. 30, 2023	789	35,851,380	(39,376,616)	(3,524,447)
Share-based compensation	4	284,629	0	284,633
Balance at Dec. 31, 2023	789	36,243,146	(43,039,462)	(6,795,527)
Net loss	0	0	(3,372,552)	(3,372,552)
Equity financing, net of issuance costs	202	5,750,870	0	5,751,072
Net settled RSUs	0	(5,872)	0	(5,872)
Share-based compensation	4	396,193	0	396,197
Balance at Mar. 31, 2024	995	42,384,337	(46,412,014)	(4,026,682)
Share-based compensation	4	396,193	0	396,197
Balance at Dec. 31, 2023	789	36,243,146	(43,039,462)	(6,795,527)
Net loss				(12,330,708)
Reclassification of historical warrants				2,759,514
Balance at Sep. 30, 2024	1,021	40,500,327	(55,370,170)	(14,868,822)
Balance at Mar. 31, 2024	995	42,384,337	(46,412,014)	(4,026,682)
Net loss	0	0	(1,756,591)	(1,756,591)
Equity financing, net of issuance costs	5	62,809	0	62,814
Net settled RSUs	0	(802)	0	(802)
Share-based compensation	6	338,030	0	338,036
Stock options exercised	0	6,000	0	6,000
Balance at Jun. 30, 2024	1,006	42,790,374	(48,168,605)	(5,377,225)
Share-based compensation	6	338,030	0	338,036
Net loss	0	0	(7,201,565)	(7,201,565)
Net settled RSUs	0	(40,874)	0	(40,874)
Share-based compensation	15	510,341	0	510,356
Reclassification of historical warrants	0	(2,759,514)	0	(2,759,514)
Balance at Sep. 30, 2024	1,021	40,500,327	(55,370,170)	(14,868,822)
Share-based compensation	$ 15	$ 510,341	$ 0	$ 510,356

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Net loss	$ (12,330,708)	$ (12,303,448)
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation and amortization	1,131,572	1,244,394
Share-based compensation	1,244,589	883,450
Non-cash interest expense related to debt financing	425,299	200,799
Accretion of notes payables	1,250,499	318,585
Impairment on property plant and equipment and operating lease	0	105,055
Change in fair value of warrant liabilities	2,623,608	0
Change in fair value of derivative liabilities	(158,000)	47,400
Loss on extinguishment of debt	1,523,221	0
Changes in assets and liabilities:
Accounts receivable	256,597	(416,512)
Inventories	(382,918)	(231,004)
Prepaid expenses	415,142	932,917
Accounts payable and accrued expenses	(92,339)	(1,764,028)
Operating lease liability	302,674	(196,597)
Net cash used in operating activities	(3,790,764)	(11,178,989)
Cash flows from investing activities
Purchases of property, plant, and equipment	(302,608)	(138,470)
Purchases of intangible assets	(371,300)	0
Net cash used in investing activities	(673,908)	(138,470)
Cash flows from financing activities
Proceeds from stock options exercised	6,000	0
Proceeds from notes payable, derivative liabilities and factoring agreement	11,516,739	10,864,539
Principal payments of notes payable and recourse factoring agreement	(19,821,023)	(7,072,726)
Proceeds from equity financing, net	24,616,598	5,440,658
Principal payments on finance lease	(726,519)	(812,315)
Repayment of finance insurance premiums	(630,700)	(421,962)
Payment of deferred offering costs	0	(144,231)
Net cash provided by financing activities	14,961,095	7,853,963
Net increase (decrease) cash	10,496,423	(3,463,496)
Cash, beginning of period	781,318	4,340,407
Cash, end of period	11,277,741	876,911
Noncash investing and financing transactions:
Reclassification of historical warrants	2,759,514	0
Modifications on finance leases	54	358,487
Conversion of debt into equity	2,794,243	0
Property and equipment additions included in accounts payable	24,200	2,000
Shares issued for prepaid services	0	100,000
Financing of property and equipment	0	512,389
Financing of insurance premiums and software	249,607	173,360
Right-of-use assets obtained through operating lease	0	7,289,971
Financing of mask set and wafer	$ 0	$ 256,693

Note 1 - Organization and Natur

Note 1 - Organization and Nature of Business	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Nature of Operations [Text Block]	1. Guerrilla RF, Inc. (formerly known as Laffin Acquisition Corp., the “Company”) was incorporated in the State of Delaware on November 9, 2020. October 22, 2021, October 20, 2021 October 22, 2021 May 30, 2023, Prior to the Merger, Laffin Acquisition Corp. was a “shell” company registered under the Securities Exchange Act of 1934, no All references in these unaudited interim condensed consolidated financial statements and related Quarterly Report to “Guerrilla RF” refer to: (i) for periods prior to May 30, 2023, Guerrilla RF designs and manufactures high‐performance Monolithic Microwave Integrated Circuits (MMICs) for the wireless infrastructure market. Guerrilla RF primarily focuses on researching and developing its existing products and building an infrastructure to handle a global distribution network; therefore, it has incurred significant start‐up losses. Risks and Uncertainties The Company is subject to several risks associated with companies at a similar stage, including dependence on key individuals, competition from similar products and larger companies, volatility of the industry, ability to obtain adequate financing to support growth, the ability to attract and retain additional qualified personnel to manage the anticipated growth of the Company, and general economic conditions including the current macro-economic conditions impacting the banking and financial markets.

Note 2 - Basis of Presentation

Note 2 - Basis of Presentation and Significant Accounting Policies	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]	2. Basis of Presentation and Principles of Consolidation The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with GAAP for interim financial information and with the rules and regulations for reporting the Quarterly Report on Form 10 10 not The condensed consolidated balance sheet at December 31, 2023 not 10 December 31, 2023 ( "2023 10 2023 10 March 29, 2024. September 30, 2024 three nine September 30, 2024 2023. three nine September 30, 2024 no Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2 1933, 2012 may not not not 404 not Further, Section 102 1 not not not may Use of Estimates The preparation of our unaudited interim condensed consolidated financial statements requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and related disclosures. The preparation of the unaudited interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim condensed consolidated financial statements, and reported amounts of revenue and expenses during the reporting period. The Company’s significant estimates and judgments involve the valuation of share-based compensation, derivatives and warrant liabilities and the valuation of equity financing. Accordingly, actual results could differ from those estimates. Reclassifications Certain prior period balance sheet and cash flow amounts have been reclassified to conform to the Company's fiscal 2024 no Segment Information Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision-maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company views its operations and manages its business in one Concentrations of Credit Risk and Major Customers Financial instruments at September 30, 2024, December 31, 2023 may not The Company’s accounts receivable are derived from revenue earned from customers located inside and outside of the U.S. Major customers are defined as those generating revenue in excess of 10% one major distributor customer, RFPD, a large product distributor serving numerous end-user customers, accounted for 78% and 81 % of product shipment revenue for the nine September 30, 2024 2023, % and 81% of accounts receivable at September 30, 2024 December 31, 2023, r espectively. Accounts Receivable Accounts receivable primarily relate to amounts due from customers, which are typically due within 30 45 one may not claims. Historically, such losses have been immaterial and within management's expectations; therefore, the Company does not The Company has a loan facility (the 'Spectrum Loan Facility') with a specialty lender, Spectrum Commercial Services Company, L.L.C ('Spectrum'). The Spectrum Loan Facility provides for advance payments up to $3.75 million, calculated, in part, based on the value of eligible accounts receivable assigned to Spectrum as security for advances under the Spectrum Loan Facility. As of September 30, 2024 ere $0.5 million o ty. At September 30, 2024 , $53 thousand of excess collateral was due from Spectrum, which is included in accounts receivable on the unaudited interim condensed consolidated balance sheets. 5 Revenue Recognition The Company recognizes product revenue when it satisfies a performance obligation by transferring a product or service to its customers in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products and services. Sales and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. Any shipping and handling fees charged to customers in conjunction with product distribution are reported within revenue. The Company does not not not not not As of September 30, 2024 2023 mpany had $0 and $250 thousand, respectively, of revenue from contracts with customers to be recognized over time as the services are delivered to the customer. Certain nonrecurring engineering service revenues are recognized over time as the services are delivered to the customer. As of September 30, 2024 2023 , the Company did not not September 30, 2024 2023 , there was no rev The costs incurred by the Company for shipping and handling of materials used in its products are classified as cost of revenue in the unaudited interim condensed consolidated statements of operations. Any incidental items that are immaterial in the context of a sale to a customer are recognized as expense. Share-Based Compensation The Company measures and recognizes compensation expense for all stock options, shares of stock, an d restricted stock units ("RSU") awarded a Estimating the fair market value of options requires the input of subjective assumptions, including the expected life of the options, stock price volatility, the risk-free interest rate, and expected dividends. Therefore, the assumptions used in the Company’s Black-Scholes option-pricing model represent management’s best estimates and involve many variables, uncertainties, and assumptions, and the application of management’s judgment, as they are inherently subjective. The Company applies ASU 2018 7, Compensation – Stock Compensation (Topic 718 , which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Share-based awards issued to non-employees are no Net Income (Loss) Per Share Basic net loss per share of common stock is computed by dividing net loss by the weighted average number of shares of common stock outstanding during each period. Holders of Series A convertible preferred stock participate in income but not In computing basic and diluted net loss per share, the weighted average number of shares is the same for both calculations because a net loss existed for the three nine September 30, 2024 2023 . There were and weighted average shares outstanding for the three September 30, 2024 and 2023, nine September 30, 2024 2023, The following potentially dilutive securities have been excluded from the computation of basic shares for th e three September 30, 2024 and 2023 unaudited ), as th ey would be anti-dilutive: Three Months Ended September 30, 2024 2023 Series A convertible preferred stock 7,213,115 - Common stock warrants 5,780,955 824,340 Restricted stock units 575,404 458,724 Stock options 389,207 609,567 13,958,681 1,892,631 Convertible Debt Instruments The Company evaluates agreements, including any convertible debt in 815 Derivatives and Hedging 815” Redeemable / Convertible Preferred Stock The Company has 10,000,000 shares of preferred stock authorized for issuance, of which, 22,000 shares have been designated as “Series A convertible preferred stock”, par value $0.0001 per share, which have a stated value of $1,000 per share and are initially convertible into 7,213,115 shares of the Company’s common stock. Holders of the Series A convertible preferred stock are entitled to vote on an as-converted basis with the Company’s common stockholders. The Company applies the accounting standards for distinguishing liabilities from equity when determining the classification and measurement of its preferred stock. Preferred shares subject to mandatory redemption are classified as liability instruments and are measured at fair value. Conditionally redeemable preferred shares (including preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not The Company evaluates its convertible instruments to determine if those contracts or embedded components of those contracts qualify as derivative financial instruments to be separately accounted for in accordance with Topic 815 Fair Value of Financial Instruments The Company measures the fair value of financial assets and liabilities based on ASC 820 820” ASC 820 820 820 three may Level 1 Level 2 Level 3 The carrying amounts of the Company’s financial instruments, such as cash and accounts payable approximate fair values due to the short-term nature of these instruments. See Note 8 3 Asset Acquisition On April 26, 2024, not 805. Going Concern Beginning in the fourth 2021, August 5, 2024, (i) reduce the outstanding principal balance from $12.0 million to $4.5 million, (ii) extend the maturity date from January 31, 2026 December 31, 2028, Management has assessed the Company's ability to continue as a going concern for one September 30, 2024. twelve twelve Recent Accounting Pronouncements In October 2021, No. 2021 08, Business Combinations 805 2021 08 606. 606 2021 08 2024 he Company adopted this accounting guidance effective January 1, 2024. not In November 2023, No. 2023 07, Segment Reporting-Improvements to Reportable Segment Disclosures 280 one December 15, 2023, December 15, 2024. not In December 2023, No. 2023 09, Income Tax-Improvements to Income Tax Disclosures 740 December 15, 2024. In November 2024, No. 2024 03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220 40 December 15, 2026, December 15, 2027. may 1 2 The Company has reviewed all other recently issued accounting pronouncements and concluded they were either not not

Note 3 - Inventories

Note 3 - Inventories	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Inventory Disclosure [Text Block]	3. Inventories are summarized as follows: September 30, 2024 (unaudited) December 31, 2023 Raw materials $ 506,958 $ 488,548 Work-in-process 50,086 132,511 Finished goods 1,382,735 922,194 Inventory allowance (23,269 ) (9,661 ) Inventories, net $ 1,916,510 $ 1,533,592

Note 4 - Property and Equipment

Note 4 - Property and Equipment	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	4. Property and equipment is summarized as follows: September 30, 2024 (unaudited) December 31, 2023 Production assets $ 2,205,460 $ 1,927,958 Computer equipment and software 959,222 937,957 Lab equipment 3,596,303 3,588,560 Office furniture and fixtures 1,290,329 1,328,570 Leasehold improvements 171,257 228,143 Construction in progress 20,353 - 8,242,924 8,011,188 Less accumulated depreciation (5,373,079 ) (4,352,104 ) $ 2,869,845 $ 3,659,084 Depreciation and amortization expense was $ and $ for the nine September 30, 2024 2023 , respectively. Impairment of Long-Lived Assets The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the asset’s carrying amount may not 360 10, 360 10 not

Note 5 - Debt

Note 5 - Debt	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Debt Disclosure [Text Block]	5. Spectrum Loan Facility On June 1, 2022 ( (ii) $500,000; 1/48 th each month during the term of the facility. The Credit Agreement also allowed for additional borrowing in an amount equal to the lesser of (i) 50% of the net amount of eligible inventory (as defined in the Credit Agreement), (ii) $350,000, and (iii) 50% of th Under the terms of the AR Agreement, Spectrum agreed to advance funds equal to approximately 85% of eligible accounts receivable that are collected by Spectrum under a “lock box” arrangement. On February 20, 2024, may The initial term of the Spectrum Loan Facility was 24 two 60 June 1, 2024. The Company’s obligations under the Spectrum Loan Facility are secured by first third In addition to annual facility fees of $37,500 and other quarterly and transaction fees payable to Spectrum, interest accrues on amounts owed under the Spectrum Loan Facility at the prime rate as quoted by the Wall Street Journal plus 3.5%, but in no The Spectrum Loan Facility contains various covenants and restrictions on the Company's financial and business operations including restrictions on the purchase or redemption of any Company shares and the declaration or payment of any dividends on the Company's stock. As of September 30, 2024, The Company has borrowe d $0.5 million September 30, 2024. $75 thousand) September 30, 2024. Salem Loan Facility On August 11, 2022, On May 1, 2023, August 2027. first three 1, 2, 3. June 30, 2023, one On August 14, 2023, August 2027. On September 5, 2023, August 11, 2027 April 30, 2024. April 30, 2024 no September 30, 2024, On September 6, 2023, On October 23, 2023, On December 18, 2023, In the second 2023, second 2023. On March 28, 2024, April 30, 2024 January 31, 2026. five March April, 2024 (' 2024 6. 470. 2024 On August 2, 2024, No. 2 August 5, 2024, January 31, 2026 December 31, 2028 September 30, 2024, As of September 30, 2024, Principal amount of promissory notes payable $ 4,500,000 Accrued interest - Less: unamortized debt issue costs - Less: unamortized debt discount - Notes payable, net $ 4,500,000 Convertible Notes Payable In July 2023, December 31, 2024 ( one x The Company analyzed the embedded features of the Convertible Notes and determined that the Convertible Notes contained (i) an automatic conversion pursuant to which the holders may not not may not one 8 On March 28, 2024, 2024 6. New Headquarters and Design Center Capital Addition Financing In conjunction with the Company's move into expanded office facilities in early 2023, April 2022. s $1.1 million , which included tax, freight, interim storage, and installatio n labor. The Company was responsible for paying interest-only payments to the financing company related to the furniture procurement order (interest on principal of $496 thousand) placed in April 2022 first August 2022 ( August 2022 September 30, 2024 April 2022 Debt Maturity As of September 30, 2024, 2024 $ 639,792 2025 767,849 2026 1,214,904 2027 1,686,449 2028 1,539,525 Thereafter - $ 5,848,519

Note 6 - Common Stock and Prefe

Note 6 - Common Stock and Preferred Stock	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Equity [Text Block]	6. COMMON STOCK AND PREFERRED STOCK Common Stock The Company is authorized to issue 50,000,000 shares of common stock with a par value of $ 0.0001. Each share of common stock entitles the holder to one may may September 30, 2024. Upon the closing of the Merger and the private placement offering in 2021 “2021 2021 45,834 2021 2021 On December 30, 2022, “2022/23 one 2022/23 February 28, 2023. In connection with the 2021 2022/23 Additionally, a total of 1,097,500 shares of common stock were issued to Salem in the years ended December 31, 2023 2022 5 On March 28, 2024, 2024 “2024 2024 one 2024 April 7, 2024, second 2024 2024 See Note 5 Common Stock Warrants As mentioned above, on February 28, 2023, 2022/23 2022/23 one one 2022/23 2022/23 five six 2022/23 2024 2024 2024 five six 2024 August 5, 2024, Each warrant is exercisable for a period of five September 30, 2024. September 30, 2024, 8 Preferred Stock The Company’s Board of Directors is authorized, subject to limitations prescribed by Delaware law, to issue preferred stock in one September 30, 2024 December 31, 2023, On August 5, 2024, August 2, 2024 ( For so long as the Buyer of the Preferred Shares beneficially owns at least 20% of the Conversion Shares underlying the Preferred Shares issued pursuant to the Purchase Agreement (the “Buyer Ownership Condition”), the Company may not, may not, August 2, 2024 ( 120 The Purchase Agreement required that the Board of Directors of the Company increase the size of the Board from eight ten Under the Purchase Agreement, the Company has agreed that for so long as the Buyer Ownership Condition is satisfied, the Buyer will have a right to participate on a pro rata basis in equity financings or issuances of securities convertible, exercisable, or exchangeable into equity securities of the Company or any subsidiaries (including debt securities with an equity component), subject to certain exceptions. The Series A convertible preferred stock is subject to automatic redemption for cash upon a “Fundamental Transaction” by the Company, which includes a merger, sale of all or substantially all the assets of the Company, recapitalization, or the sale of more than 50% of the voting stock of the Company which results in the Series A convertible preferred stock being classified as temporary equity. In such event, the redemption price would be equal to the greater of the stated value of the Series A convertible preferred stock or the consideration per share of common stock in the Fundamental Transaction (or in the absence of such consideration, the volume-weighted average price of the Company’s common stock immediately preceding the closing of the Fundamental Transaction). Additionally, after analyzing the cashless exercise provision within the North Run Warrants, the Company has determined that the North Run Warrants are classified as liabilities to be carried at fair value (See Note 8 not not

Note 7 - Share-based Compensati

Note 7 - Share-based Compensation	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Share-Based Payment Arrangement [Text Block]	7. In 2014, “2014 2014 2014 No may 2014 In 2021, “2021 not 2014 2021 2021 2021 January 1 2031 December 31, may The general purpose of the 2014 2021 Stock Option Awards The Company measures the fair value of each option award on the date of grant using the Black‐Scholes option-pricing model, which takes into account inputs such as the exercise price, the value of the underlying ordinary shares at the grant date, expected term, expected volatility, risk-free interest rate, and dividend yield. The fair value of each grant of options during the nine September 30, 2024 ● The expected term of employee options is determined using the “simplified” method, as prescribed in the SEC’s Staff Accounting Bulletin (SAB) No. 107, ● The expected volatility is based on the historical volatility of the publicly traded common stock of a peer group of companies. ● The risk-free interest rate is based on the interest rate payable on U.S. Treasury securities in effect at the time of grant for a period that is commensurate with the assumed expected term. ● The expected dividend yield is zero because the Company has not not GUERRILLA RF, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) No three September 30, 2024. three September 30, 2024 Stock option activity by share is summarized as follows for the three September 30, 2024 ( unaudited Number of Shares Weighted-Average Exercise Price Per Option Weighted- Average Remaining Contractual Life (in years) Shares underlying outstanding awards at December 31, 2023 570,748 $ 7.67 5.98 Granted - - Exercised - - Cancelled/forfeited - - Shares underlying outstanding awards at March 31, 2024 570,748 $ 7.67 5.73 Granted 8,500 2.50 Exercised 2,950 2.03 Cancelled/forfeited - Shares underlying outstanding awards at June 30, 2024 576,298 $ 7.63 5.54 Granted - Exercised 67,380 2.02 Cancelled/forfeited 119,711 2.03 Shares underlying outstanding awards at September 30, 2024 389,207 $ 8.90 6.49 Exercisable options at September 30, 2024 337,521 $ 7.13 5.91 The aggregate intrinsic value of outstanding options exercisable as of September 30, 2024 was $0.2 million. As of September 30, 2024 , stock-based compensation of $0.2 million for unvested options will be recognized over a remaining weighted-average requisite service period of two GUERRILLA RF, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) RSU Awards There were 114,764 RSUs awarded to employees during the three September 30, 2024. September 30, 2024 ly $1.8 The fair value of each RSU was estimated on the date of grant, based on the weighted average price of the Company's stock. The Company will issue new shares of common stock to satisfy RSUs upon vesting. The following table summarizes the RSU activity and weighted averages for share-based awards granted under the terms of the 2021 Three Months Ended September 30, 2024 Number of RSUs Weighted Average Grant Date Fair Value Outstanding at June 30, 2024 588,746 $ 5.66 Granted 114,764 2.50 Vested (128,106 ) 4.50 Cancelled/forfeited - Outstanding at September 30, 2024 575,404 $ 5.53 Pursuant to awards made under the 2014 2021 three m onths ended September 30, 2024 2023 : Nine Months Ended September 30, 2024 2023 Direct product costs $ 79,630 $ 54,328 Research and development 400,107 198,689 Sales and marketing 284,409 138,983 General and administrative 480,443 491,450 $ 1,244,589 $ 883,450 No income tax benefits have been recognized in the unaudited interim condensed consolidated statements of operations for stock-based compensation arrangements, and no stock-based compensation costs have been capitalized as property and equipment through September 30, 2024. GUERRILLA RF, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

Note 8 - Derivative Liabilities

Note 8 - Derivative Liabilities	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Derivative Instruments and Hedging Activities Disclosure [Text Block]	8. Derivative Liabilities As of January 1, 2024, 3 March 28, 2024, March 28, 2024, September 30, 2024, no 5 The following table sets forth a summary of the changes in the fair value of Level 3 Beginning balance as of January 1, 2024 $ 158,000 Change in fair value of derivative liabilities (158,000 ) Ending balance on September 30, 2024 $ - Warrant Liabilities The Company determined that the North Run Warrants should be accounted for as Level 3 The Monte Carlo simulation considered assumptions including the number of trials, warrant dilution, bid price estimates and multiple VWAP amounts for the cashless conversions of the North Run Warrants. Additionally, other key assumptions used in the Monte-Carlo simulation include the risk free rate, the expected term of the warrants, expected stock price volatility and expected dividends. The following table summarizes the significant assumptions used in the Monte-Carlo simulation during the three nine September 30, 2024: The following table summarizes the Monte-Carlo assumptions used during the three nine September 30, 2024: For the Three and Nine Months Ended September 30, 2024 Risk free interest rate 3.55% 3.58% Expected term (years) 5.35 5.5 Expected volatility 42.60% 43.20% Expected dividends 0.00% In connection with the North Run Private Placement, the Company determined it should reclassify warrants to purchase an aggregate 2,895,709 shares of common stock (the “Historical Warrants”) as Level 3 The following table summarizes the Black-Scholes assumptions used during the three nine September 30, 2024: For the Three and Nine Months Ended September 30, 2024 Risk free interest rate 3.58% - 3.71% Expected term (years) 2.57 - 5.15 Expected volatility 51.30% - 60.80% Expected dividends 0.00% The following table sets forth a summary of the changes in the fair value of Level 3 Beginning balance as of January 1, 2024 $ - Reclassification of Historical Warrants 2,759,514 Issuance of warrant liabilities 1,563,400 Change in fair value of derivative liabilities 2,623,608 Ending balance on September 30, 2024 $ 6,946,522 GUERRILLA RF, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

Note 9 - Commitments and Contin

Note 9 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	9. Lease Commitments The Company determines whether an arrangement is an operating lease or financing lease at inception. Lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the term of the lease. The Company generally uses its incremental borrowing rate, which is based on information available at the lease commencement date, to determine the present value of lease payments. The Company has entered into leases primarily for real estate and equipment used in research and development. Operating lease expense is recognized in continuing operations by amortizing the amount recorded as an asset on a straight-line basis over the lease term. Financing lease expense is comprised of both interest expense, which will be recognized using the effective interest method, and amortization of the right-of-use assets. These expenses are presented consistently with other interest expense and amortization or depreciation of similar assets. In determining lease asset values, the Company considers fixed and variable payment terms, prepayments, incentives, and options to extend, terminate or purchase. Renewal, termination, or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised. Balance sheet information related to right-of-use assets and liabilities is as follows: Balance Sheet Location September 30, 2024 Operating Leases: Operating lease right-of-use assets Operating lease right-of-use assets $ 9,627,914 Current portion of operating lease liabilities Operating lease, current portion 657,978 Noncurrent portion of operating lease liabilities Operating lease 5,694,467 Total operating lease liabilities $ 6,352,445 Finance Leases: Finance lease right-of-use assets Property, plant, and equipment $ 1,736,013 Current portion of finance lease liabilities Finance lease, current portion 800,091 Noncurrent portion of finance lease liabilities Finance lease 1,045,966 Total finance lease liabilities $ 1,846,057 Lease cost recognized in the unaudited interim condensed consolidated statements of operations is summarized as follows: For the Nine Months Ended September 30, 2024 2023 Operating lease cost $ 1,414,790 $ 1,210,436 Finance lease cost: Amortization of lease assets 797,910 944,413 Interest on lease liabilities 125,419 198,778 Total finance lease costs $ 923,329 $ 1,143,191 Other supplemental information related to leases is summarized as follows: September 30, 2024 Weighted average remaining lease term (in years): Operating leases 8.17 Finance leases 2.45 Weighted average discount rate: Operating leases 11.02 % Finance leases 7.74 % Cash paid for amounts included in the measurement of lease liabilities for the nine months ended September 30, 2024: Operating cash flows from operating leases $ 1,112,118 Operating cash flows from finance leases $ 124,106 Financing cash flows from finance leases $ 726,519 The following table summarizes our future minimum payments under contractual obligations for operating and financing liabilities as of September 30, 2024 : Payments Due by Period 2024 (1) 2025 2026 2027 2028 Thereafter Total Operating leases $ 347,862 $ 1,233,668 $ 1,056,589 $ 1,076,140 $ 1,096,206 $ 4,890,149 $ 9,700,614 Less present value adjustment 171,926 635,214 580,820 524,555 460,933 974,721 3,348,169 Operating lease liabilities $ 175,936 $ 598,454 $ 475,769 $ 551,585 $ 635,273 $ 3,915,428 $ 6,352,445 Finance leases $ 283,979 $ 815,150 $ 722,306 $ 156,861 $ 49,664 $ 10,702 $ 2,038,662 Less interest 33,538 97,612 46,269 11,256 3,787 143 192,605 Finance lease liabilities $ 250,441 $ 717,538 $ 676,037 $ 145,605 $ 45,877 $ 10,559 $ 1,846,057 ( 1 three December 31, 2024. Legal In the ordinary course of business, the Company may not sult, no liability r September 30, 2024 December 31, 2023 Indemnification Agreements From time to time, in the ordinary course of business, the Company may may third may not not no liability f September 30, 2024 December 31, 2023 Employment Agreement The Company has entered into an employment agreement with one January 1, 2020 may twelve Salary Deferral Program In 2023, June 28, 2023, September 4, 2023, 2024 January 1, 2024. March 2024

Note 10 - Income Taxes

Note 10 - Income Taxes	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Income Tax Disclosure [Text Block]	10. The Company did not nine September 30, 2024 2023. Income tax expense during interim periods is based on applying an estimated annual effective income tax rate to year-to-date income, plus any significant unusual or infrequently occurring items recorded in the interim period. The provision for income taxes for the three September 30, 2024 2023 The computation of the annual estimated effective tax rate at each interim period requires certain estimates and significant judgment including, but not may In assessing the need for a valuation allowance, management must determine that there will be sufficient taxable income to realize deferred tax assets. Based upon the historical and anticipated future losses, management has determined that the deferred tax assets do not not September 30, 2024, December 31, 2023. Deferred tax assets and liabilities are determined based on the differences between the unaudited interim condensed consolidated financial statement carrying amounts and tax bases of assets and liabilities using enacted tax rates in effect for years in which differences are expected to reverse. Potential 382 At December 31, 2023, The Company’s ability to utilize its net operating loss ("NOL") and research and development ("R&D") credit carryforwards may 382 1986 , may 382 three 50 If the Company experiences an ownership change, utilization of the NOL or R&D credit carryforwards would be subject to an annual limitation, which is determined by first 382 may In 2022 , one 382 . not 2014 . may 382 no 740. not

Note 11 - Related Party Transac

Note 11 - Related Party Transactions	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	11. See Note 5 2024 See Note 5 2024 Participation in the 2024 Certain existing shareholders, including investors affiliated with certain of our directors and officers, purchased an aggregate of 612,473 Units in conjunction with the initial closing of the 2024 March 28, 2024. GUERRILLA RF, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

Note 12 - Employee Benefit Plan

Note 12 - Employee Benefit Plan	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Retirement Benefits [Text Block]	12. The Company has a 401 may 401 may four any ma de $83,589 and $87,205 of contributi three September 30, 2024 2023,

Note 13 - Subsequent Events

Note 13 - Subsequent Events	9 Months Ended
	Sep. 30, 2024
Notes to Financial Statements
Subsequent Events [Text Block]	13. None.

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2024
Insider Trading Arr Line Items
Material Terms of Trading Arrangement [Text Block]		5. Trading Arrangements of Section 16 During the quarter ended September 30, 2024 no 16 1934, 10b5 1 10b5 1 229.408
Rule 10b5-1 Arrangement Terminated [Flag]	false
Rule 10b5-1 Arrangement Adopted [Flag]	false
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation and Principles of Consolidation The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with GAAP for interim financial information and with the rules and regulations for reporting the Quarterly Report on Form 10 10 not The condensed consolidated balance sheet at December 31, 2023 not 10 December 31, 2023 ( "2023 10 2023 10 March 29, 2024. September 30, 2024 three nine September 30, 2024 2023. three nine September 30, 2024 no
Emerging Growth Company [Policy Text Block]	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2 1933, 2012 may not not not 404 not Further, Section 102 1 not not not may
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of our unaudited interim condensed consolidated financial statements requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and related disclosures. The preparation of the unaudited interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim condensed consolidated financial statements, and reported amounts of revenue and expenses during the reporting period. The Company’s significant estimates and judgments involve the valuation of share-based compensation, derivatives and warrant liabilities and the valuation of equity financing. Accordingly, actual results could differ from those estimates.
Reclassification, Comparability Adjustment [Policy Text Block]	Reclassifications Certain prior period balance sheet and cash flow amounts have been reclassified to conform to the Company's fiscal 2024 no
Segment Reporting, Policy [Policy Text Block]	Segment Information Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision-maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company views its operations and manages its business in one
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of Credit Risk and Major Customers Financial instruments at September 30, 2024, December 31, 2023 may not The Company’s accounts receivable are derived from revenue earned from customers located inside and outside of the U.S. Major customers are defined as those generating revenue in excess of 10% one major distributor customer, RFPD, a large product distributor serving numerous end-user customers, accounted for 78% and 81 % of product shipment revenue for the nine September 30, 2024 2023, % and 81% of accounts receivable at September 30, 2024 December 31, 2023, r espectively.
Accounts Receivable [Policy Text Block]	Accounts Receivable Accounts receivable primarily relate to amounts due from customers, which are typically due within 30 45 one may not claims. Historically, such losses have been immaterial and within management's expectations; therefore, the Company does not The Company has a loan facility (the 'Spectrum Loan Facility') with a specialty lender, Spectrum Commercial Services Company, L.L.C ('Spectrum'). The Spectrum Loan Facility provides for advance payments up to $3.75 million, calculated, in part, based on the value of eligible accounts receivable assigned to Spectrum as security for advances under the Spectrum Loan Facility. As of September 30, 2024 ere $0.5 million o ty. At September 30, 2024 , $53 thousand of excess collateral was due from Spectrum, which is included in accounts receivable on the unaudited interim condensed consolidated balance sheets. 5
Revenue [Policy Text Block]	Revenue Recognition The Company recognizes product revenue when it satisfies a performance obligation by transferring a product or service to its customers in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products and services. Sales and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. Any shipping and handling fees charged to customers in conjunction with product distribution are reported within revenue. The Company does not not not not not As of September 30, 2024 2023 mpany had $0 and $250 thousand, respectively, of revenue from contracts with customers to be recognized over time as the services are delivered to the customer. Certain nonrecurring engineering service revenues are recognized over time as the services are delivered to the customer. As of September 30, 2024 2023 , the Company did not not September 30, 2024 2023 , there was no rev The costs incurred by the Company for shipping and handling of materials used in its products are classified as cost of revenue in the unaudited interim condensed consolidated statements of operations. Any incidental items that are immaterial in the context of a sale to a customer are recognized as expense.
Share-Based Payment Arrangement [Policy Text Block]	Share-Based Compensation The Company measures and recognizes compensation expense for all stock options, shares of stock, an d restricted stock units ("RSU") awarded a Estimating the fair market value of options requires the input of subjective assumptions, including the expected life of the options, stock price volatility, the risk-free interest rate, and expected dividends. Therefore, the assumptions used in the Company’s Black-Scholes option-pricing model represent management’s best estimates and involve many variables, uncertainties, and assumptions, and the application of management’s judgment, as they are inherently subjective. The Company applies ASU 2018 7, Compensation – Stock Compensation (Topic 718 , which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Share-based awards issued to non-employees are no
Earnings Per Share, Policy [Policy Text Block]	Net Income (Loss) Per Share Basic net loss per share of common stock is computed by dividing net loss by the weighted average number of shares of common stock outstanding during each period. Holders of Series A convertible preferred stock participate in income but not In computing basic and diluted net loss per share, the weighted average number of shares is the same for both calculations because a net loss existed for the three nine September 30, 2024 2023 . There were and weighted average shares outstanding for the three September 30, 2024 and 2023, nine September 30, 2024 2023, The following potentially dilutive securities have been excluded from the computation of basic shares for th e three September 30, 2024 and 2023 unaudited ), as th ey would be anti-dilutive: Three Months Ended September 30, 2024 2023 Series A convertible preferred stock 7,213,115 - Common stock warrants 5,780,955 824,340 Restricted stock units 575,404 458,724 Stock options 389,207 609,567 13,958,681 1,892,631
Debt, Policy [Policy Text Block]	Convertible Debt Instruments The Company evaluates agreements, including any convertible debt in 815 Derivatives and Hedging 815”
Stockholders' Equity Note, Redeemable Preferred Stock, Issue, Policy [Policy Text Block]	Redeemable / Convertible Preferred Stock The Company has 10,000,000 shares of preferred stock authorized for issuance, of which, 22,000 shares have been designated as “Series A convertible preferred stock”, par value $0.0001 per share, which have a stated value of $1,000 per share and are initially convertible into 7,213,115 shares of the Company’s common stock. Holders of the Series A convertible preferred stock are entitled to vote on an as-converted basis with the Company’s common stockholders. The Company applies the accounting standards for distinguishing liabilities from equity when determining the classification and measurement of its preferred stock. Preferred shares subject to mandatory redemption are classified as liability instruments and are measured at fair value. Conditionally redeemable preferred shares (including preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not The Company evaluates its convertible instruments to determine if those contracts or embedded components of those contracts qualify as derivative financial instruments to be separately accounted for in accordance with Topic 815
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments The Company measures the fair value of financial assets and liabilities based on ASC 820 820” ASC 820 820 820 three may Level 1 Level 2 Level 3 The carrying amounts of the Company’s financial instruments, such as cash and accounts payable approximate fair values due to the short-term nature of these instruments. See Note 8 3
Asset Acquisition [Policy Text Block]	Asset Acquisition On April 26, 2024, not 805.
Going Concern [Policy Text Block]	Going Concern Beginning in the fourth 2021, August 5, 2024, (i) reduce the outstanding principal balance from $12.0 million to $4.5 million, (ii) extend the maturity date from January 31, 2026 December 31, 2028, Management has assessed the Company's ability to continue as a going concern for one September 30, 2024. twelve twelve
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements In October 2021, No. 2021 08, Business Combinations 805 2021 08 606. 606 2021 08 2024 he Company adopted this accounting guidance effective January 1, 2024. not In November 2023, No. 2023 07, Segment Reporting-Improvements to Reportable Segment Disclosures 280 one December 15, 2023, December 15, 2024. not In December 2023, No. 2023 09, Income Tax-Improvements to Income Tax Disclosures 740 December 15, 2024. In November 2024, No. 2024 03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220 40 December 15, 2026, December 15, 2027. may 1 2 The Company has reviewed all other recently issued accounting pronouncements and concluded they were either not not

Note 2 - Basis of Presentatio_2

Note 2 - Basis of Presentation and Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Three Months Ended September 30, 2024 2023 Series A convertible preferred stock 7,213,115 - Common stock warrants 5,780,955 824,340 Restricted stock units 575,404 458,724 Stock options 389,207 609,567 13,958,681 1,892,631

Note 3 - Inventories (Tables)

Note 3 - Inventories (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Schedule of Inventory, Current [Table Text Block]	September 30, 2024 (unaudited) December 31, 2023 Raw materials $ 506,958 $ 488,548 Work-in-process 50,086 132,511 Finished goods 1,382,735 922,194 Inventory allowance (23,269 ) (9,661 ) Inventories, net $ 1,916,510 $ 1,533,592

Note 4 - Property and Equipme_2

Note 4 - Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Property, Plant and Equipment [Table Text Block]	September 30, 2024 (unaudited) December 31, 2023 Production assets $ 2,205,460 $ 1,927,958 Computer equipment and software 959,222 937,957 Lab equipment 3,596,303 3,588,560 Office furniture and fixtures 1,290,329 1,328,570 Leasehold improvements 171,257 228,143 Construction in progress 20,353 - 8,242,924 8,011,188 Less accumulated depreciation (5,373,079 ) (4,352,104 ) $ 2,869,845 $ 3,659,084

Note 5 - Debt (Tables)

Note 5 - Debt (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Schedule of Line of Credit Facilities [Table Text Block]	Principal amount of promissory notes payable $ 4,500,000 Accrued interest - Less: unamortized debt issue costs - Less: unamortized debt discount - Notes payable, net $ 4,500,000
Schedule of Maturities of Long-Term Debt [Table Text Block]	2024 $ 639,792 2025 767,849 2026 1,214,904 2027 1,686,449 2028 1,539,525 Thereafter - $ 5,848,519

Note 7 - Share-based Compensa_2

Note 7 - Share-based Compensation (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Number of Shares Weighted-Average Exercise Price Per Option Weighted- Average Remaining Contractual Life (in years) Shares underlying outstanding awards at December 31, 2023 570,748 $ 7.67 5.98 Granted - - Exercised - - Cancelled/forfeited - - Shares underlying outstanding awards at March 31, 2024 570,748 $ 7.67 5.73 Granted 8,500 2.50 Exercised 2,950 2.03 Cancelled/forfeited - Shares underlying outstanding awards at June 30, 2024 576,298 $ 7.63 5.54 Granted - Exercised 67,380 2.02 Cancelled/forfeited 119,711 2.03 Shares underlying outstanding awards at September 30, 2024 389,207 $ 8.90 6.49 Exercisable options at September 30, 2024 337,521 $ 7.13 5.91
Nonvested Restricted Stock Shares Activity [Table Text Block]	Three Months Ended September 30, 2024 Number of RSUs Weighted Average Grant Date Fair Value Outstanding at June 30, 2024 588,746 $ 5.66 Granted 114,764 2.50 Vested (128,106 ) 4.50 Cancelled/forfeited - Outstanding at September 30, 2024 575,404 $ 5.53
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Nine Months Ended September 30, 2024 2023 Direct product costs $ 79,630 $ 54,328 Research and development 400,107 198,689 Sales and marketing 284,409 138,983 General and administrative 480,443 491,450 $ 1,244,589 $ 883,450

Note 8 - Derivative Liabiliti_2

Note 8 - Derivative Liabilities (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]	Beginning balance as of January 1, 2024 $ 158,000 Change in fair value of derivative liabilities (158,000 ) Ending balance on September 30, 2024 $ -
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Beginning balance as of January 1, 2024 $ - Reclassification of Historical Warrants 2,759,514 Issuance of warrant liabilities 1,563,400 Change in fair value of derivative liabilities 2,623,608 Ending balance on September 30, 2024 $ 6,946,522
North Run Warrants [Member]
Notes Tables
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]	For the Three and Nine Months Ended September 30, 2024 Risk free interest rate 3.55% 3.58% Expected term (years) 5.35 5.5 Expected volatility 42.60% 43.20% Expected dividends 0.00% For the Three and Nine Months Ended September 30, 2024 Risk free interest rate 3.58% - 3.71% Expected term (years) 2.57 - 5.15 Expected volatility 51.30% - 60.80% Expected dividends 0.00%

Note 9 - Commitments and Cont_2

Note 9 - Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Tables
Assets and Liabilities, Lessee [Table Text Block]	Balance Sheet Location September 30, 2024 Operating Leases: Operating lease right-of-use assets Operating lease right-of-use assets $ 9,627,914 Current portion of operating lease liabilities Operating lease, current portion 657,978 Noncurrent portion of operating lease liabilities Operating lease 5,694,467 Total operating lease liabilities $ 6,352,445 Finance Leases: Finance lease right-of-use assets Property, plant, and equipment $ 1,736,013 Current portion of finance lease liabilities Finance lease, current portion 800,091 Noncurrent portion of finance lease liabilities Finance lease 1,045,966 Total finance lease liabilities $ 1,846,057
Lease, Cost [Table Text Block]	For the Nine Months Ended September 30, 2024 2023 Operating lease cost $ 1,414,790 $ 1,210,436 Finance lease cost: Amortization of lease assets 797,910 944,413 Interest on lease liabilities 125,419 198,778 Total finance lease costs $ 923,329 $ 1,143,191
Other Supplemental Lease Information [Table Text Block]	September 30, 2024 Weighted average remaining lease term (in years): Operating leases 8.17 Finance leases 2.45 Weighted average discount rate: Operating leases 11.02 % Finance leases 7.74 % Cash paid for amounts included in the measurement of lease liabilities for the nine months ended September 30, 2024: Operating cash flows from operating leases $ 1,112,118 Operating cash flows from finance leases $ 124,106 Financing cash flows from finance leases $ 726,519
Lease, Liability, Fiscal Year Maturity [Table Text Block]	Payments Due by Period 2024 (1) 2025 2026 2027 2028 Thereafter Total Operating leases $ 347,862 $ 1,233,668 $ 1,056,589 $ 1,076,140 $ 1,096,206 $ 4,890,149 $ 9,700,614 Less present value adjustment 171,926 635,214 580,820 524,555 460,933 974,721 3,348,169 Operating lease liabilities $ 175,936 $ 598,454 $ 475,769 $ 551,585 $ 635,273 $ 3,915,428 $ 6,352,445 Finance leases $ 283,979 $ 815,150 $ 722,306 $ 156,861 $ 49,664 $ 10,702 $ 2,038,662 Less interest 33,538 97,612 46,269 11,256 3,787 143 192,605 Finance lease liabilities $ 250,441 $ 717,538 $ 676,037 $ 145,605 $ 45,877 $ 10,559 $ 1,846,057

Note 2 - Basis of Presentatio_3

Note 2 - Basis of Presentation and Significant Accounting Policies (Details Textual)							3 Months Ended		9 Months Ended		12 Months Ended
	Aug. 02, 2024 USD ($) shares	Apr. 26, 2024 USD ($)	Feb. 20, 2024 USD ($)	Sep. 06, 2023 USD ($) shares	Aug. 14, 2023 USD ($) shares	Jun. 01, 2022 USD ($)	Sep. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2023 USD ($) shares	Sep. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2023 USD ($) shares	Dec. 31, 2023 $ / shares shares	Dec. 31, 2021 shares	Aug. 05, 2024 USD ($) $ / shares shares	Aug. 01, 2024 USD ($)	Jun. 30, 2024 USD ($)	Oct. 23, 2023 USD ($)	Sep. 05, 2023	Jun. 30, 2023 USD ($)	May 01, 2023 USD ($)	Aug. 11, 2022 USD ($)
Accounts Receivable Secured Debt Facility, Receivables Assigned							$ 0.5		$ 0.5
Accounts Receivable Secured Debt Facility, Amount Due							53		53
Contract with Customer, Liability, Revenue To Be Recognized									0	$ 250,000
Contract with Customer, Liability							0	$ 0	$ 0	$ 0
Contract with Customer, Performance Obligation Satisfied in Previous Period							$ 0	$ 0
Weighted Average Number of Shares Outstanding, Basic (in shares) | shares							10,139,230	7,211,095	9,392,326	6,841,253
Preferred Stock, Shares Authorized (in shares) | shares							9,978,000		9,978,000		9,978,000		10,000,000
Preferred Stock, Shares Outstanding (in shares) | shares							0		0		0
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares							$ 0.0001		$ 0.0001		$ 0.0001
Stock Issued During Period, Shares, New Issues (in shares) | shares												5,524,534
Proceeds from Issuance of Preferred Stock and Preference Stock	$ 21,600,000
Salem Loan Facility [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares				660,000	400,000
Long-Term Line of Credit	$ 4,500,000			$ 1,750,000	$ 1,500,000		$ 4,500,000		$ 4,500,000					$ 12,000,000	$ 12,000,000	$ 1,250,000		$ 5,500,000	$ 1,500,000	$ 5,000,000
Debt Instrument, Interest Rate, Stated Percentage					14%		14%		14%					14%			14%
Debt Instrument, Interest Rate, Stated Percentage, Paid in Kind							3%		3%					3%
Debt Instrument, Interest Rate, Stated Percentage, Paid in Cash	12%						11%		11%					11%
Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares	22,000
Gallium Semiconductor's GaN Power Amplifiers and Front-end Modules [Member]
Asset Acquisition, Consideration Transferred		$ 400,000
Finite-Lived Intangible Assets Acquired		$ 400,000
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life (Year)		10 years
Series A Convertible Preferred Stock [Member]
Preferred Stock, Shares Outstanding (in shares) | shares							22,000		22,000		0		22,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares													$ 0.0001
Preferred Stock, Stated Value													$ 1,000
Preferred Stock, Convertible, Shares Issuable (in shares) | shares													7,213,115
Spectrum Loan Facility [Member]
Proceeds from Accounts Receivable Factoring			$ 3,750,000			$ 3,000,000
Long-Term Line of Credit							$ 500,000		$ 500,000
Customer Concentration Risk [Member] | Revenue Benchmark [Member]
Number of Major Customers									1	1
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | One Customer [Member]
Concentration Risk, Percentage									78%	81%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | One Customer [Member]
Concentration Risk, Percentage									71%		81%

Note 2 - Basis of Presentatio_4

Note 2 - Basis of Presentation and Significant Accounting Policies - Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share (Details) - shares	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	13,958,681	1,892,631
Series A Convertible Preferred Stock [Member]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	7,213,115	0
Common Stock Warrants [Member]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	5,780,955	824,340
Restricted Stock Units (RSUs) [Member]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	575,404	458,724
Share-Based Payment Arrangement, Option [Member]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	389,207	609,567

Note 3 - Inventories - Summary

Note 3 - Inventories - Summary of Inventories (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Raw materials	$ 506,958	$ 488,548
Work-in-process	50,086	132,511
Finished goods	1,382,735	922,194
Inventory allowance	(23,269)	(9,661)
Inventories, net	$ 1,916,510	$ 1,533,592

Note 4 - Property and Equipme_3

Note 4 - Property and Equipment (Details Textual) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Depreciation	$ 1,131,572	$ 1,244,394

Note 4 - Property and Equipme_4

Note 4 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Property and equipment, gross	$ 8,242,924	$ 8,011,188
Less accumulated depreciation	(5,373,079)	(4,352,104)
Property, Plant and Equipment, Net	2,869,845	3,659,084
Production Assets [Member]
Property and equipment, gross	2,205,460	1,927,958
Computer Equipment and Software [Member]
Property and equipment, gross	959,222	937,957
Lab Equipment [Member]
Property and equipment, gross	3,596,303	3,588,560
Furniture and Fixtures [Member]
Property and equipment, gross	1,290,329	1,328,570
Leasehold Improvements [Member]
Property and equipment, gross	171,257	228,143
Construction in Progress [Member]
Property and equipment, gross	$ 20,353	$ 0

Note 5 - Debt (Details Textual)

Note 5 - Debt (Details Textual) - USD ($)													1 Months Ended			3 Months Ended						9 Months Ended		12 Months Ended
	Aug. 02, 2024	Mar. 28, 2024	Feb. 20, 2024	Dec. 18, 2023	Oct. 23, 2023	Sep. 06, 2023	Sep. 05, 2023	Aug. 14, 2023	Jun. 30, 2023	May 01, 2023	Aug. 11, 2022	Jun. 01, 2022	Jul. 31, 2023	Aug. 31, 2022	Apr. 30, 2022	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2021	Aug. 01, 2024	Feb. 28, 2022
Stock Issued During Period, Value, New Issues																	$ 62,814	$ 5,751,072	$ 1,685,226	$ 96,757	$ 3,658,675
Stock Issued During Period, Shares, New Issues (in shares)																								5,524,534
Paid-in-Kind Interest																						$ 425,299	$ 200,799
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)																										769,146
Gain (Loss) on Extinguishment of Debt																$ (1,523,221)			$ 0			(1,523,221)	$ 0
Warrants From Debt Conversion [Member]
Warrants and Rights Outstanding, Term (Year)		5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)		261,723
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)		$ 2.5
Conversion Debt into Equity [Member]
Debt Conversion, Converted Instrument, Shares Issued (in shares)		261,723
Salem Loan Facility [Member]
Long-Term Line of Credit	$ 4,500,000				$ 1,250,000	$ 1,750,000		$ 1,500,000	$ 5,500,000	$ 1,500,000	$ 5,000,000					$ 4,500,000	$ 12,000,000			5,500,000		$ 4,500,000			$ 12,000,000
Line of Credit Facility, Maximum Borrowing Capacity											$ 8,000,000
Line of Credit Facility, Interest Rate During Period, Paid-in-Kind		3%								3%	2%
Common Stock, Shares, Issued as Consideration (in shares)											25,000
Line of Credit Facility, Remaining Borrowing Capacity				$ 1,000,000							$ 3,000,000
Line of Credit Facility, Interest Rate During Period										14%	13%
Line of Credit Facility, Interest Rate During Period, Paid in Cash										11%
Debt Instrument, Fee Amount		$ 100,000		$ 45	$ 43,000,000	$ 88,000		$ 45,000		$ 60,000
Stock Issued During Period, Value, New Issues										12,500
Common Stock, Value, Issued as Consideration										$ 1,500,000
Line of Credit Facility, Allocated Interest Rate				26%	21%	104%		28%		17%
Extinguishment of Debt, Prepaid Premium Year 1, Percentage											3%
Extinguishment of Debt, Prepaid Premium Year 2, Percentage											2%
Extinguishment of Debt, Prepaid Premium Year 3, Percentage											1%
Debt Instrument, Interest Rate, Stated Percentage							14%	14%								14%						14%			14%
Debt Issuance Cost, Gross, Noncurrent								$ 78,000
Stock Issued During Period, Shares, New Issues (in shares)						660,000		400,000
Line of Credit Facility, Additional Maximum Borrowing Capacity							$ 4,000,000
Proceeds from Lines of Credit						$ 1,750,000
Line of Credit Facility, Interest Rate at Period End		11%
Paid-in-Kind Interest		$ 654,308
Debt Instrument, Interest Rate, Effective Percentage		16.90%
Debt Instrument, Unamortized Discount		$ 1,278,516
Equity Exchanged for Debt Instrument Interest, Value		$ 1,932,824
Debt Instrument, Interest Rate, Stated Percentage, Paid in Kind																3%						3%			3%
Debt Instrument, Interest Rate, Stated Percentage, Paid in Cash	12%															11%						11%			11%
Gain (Loss) on Extinguishment of Debt	$ (1,500,000)
Salem Loan Facility [Member] | AMB Investments, LLC, Participation Rights in Underlying Loan [Member]
Long-Term Line of Credit									$ 2,600,000											$ 2,600,000
Stock Issued During Period, Shares, New Issues (in shares)									500,000
Participation Interest in Underlying Loan, Ownership Percentage									47.17%											47.17%
Salem Loan Facility [Member] | Minimum [Member]
Line of Credit Facility, Allocated Interest Rate							29%
Salem Loan Facility [Member] | Maximum [Member]
Line of Credit Facility, Allocated Interest Rate							98%
Spectrum Loan Facility [Member]
Percent, Cost of Eligible Equipment												75%
Monthly Reduction of Maximum Funds Available to Purchase Eligible Equipment, Percentage												0.021%
Percent, Net Amount of Eligible Inventory												50%
Additional Amount Allowed to be Borrowed												$ 350,000
Percent of Purchased Accounts Receivable Outstanding												50%
Percent of Eligible Accounts Receivable												85%
Proceeds from Accounts Receivable Factoring			$ 3,750,000									$ 3,000,000
Annual Facility Fees			$ 37,500
Debt Instrument, Basis Spread on Variable Rate												3.50%
Debt Instrument, Base Floor												7%
Long-Term Line of Credit																$ 500,000						$ 500,000
Interest Expense, Operating and Nonoperating																						$ 75,000
Convertible Promissory Notes [Member]
Debt Instrument, Face Amount													$ 790,000
Convertible Note, Repayment Amount, Percent of Amount Due, Benchmark													20%
Debt Instrument, Convertible, Conversion Price (in dollars per share)													$ 6
Convertible Promissory Notes [Member] | Put Option [Member]
Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral													$ 15,800
Convertible Promissory Notes [Member] | New Equity Financing [Member]
Minimum Gross Proceeds Received From Issuance of Equity Securities for Conversion of Note													2,000,000
Convertible Promissory Notes [Member] | Chief Executive Officer and Family Members [Member]
Debt Instrument, Face Amount													710,000
Convertible Promissory Notes [Member] | Chief Executive Officer [Member]
Debt Instrument, Face Amount													80,000
Convertible Promissory Notes [Member] | Chief Executive Officer Family Members [Member]
Debt Instrument, Face Amount													$ 630,000
Convertible Notes, One [Member]
Debt Instrument, Interest Rate, Stated Percentage													8%				9.40%
Debt Instrument, Face Amount													$ 290,000				$ 290,000
Convertible Notes, Two [Member]
Debt Instrument, Interest Rate, Stated Percentage													16%				17.40%
Debt Instrument, Face Amount													$ 500,000				$ 500,000
Financing Arrangement Related to Furniture for New Office Facilities [Member]
Debt Instrument, Face Amount															$ 1,100,000
Debt Instrument, Periodic Payment, Interest														$ 17,000	$ 496,000
Debt Instrument, Periodic Payment, Principal														$ 246,000
Debt Instrument, Periodic Payment																$ 111,000

Note 5 - Debt - Financing Under

Note 5 - Debt - Financing Under Credit Facility (Details) - Salem Loan Facility [Member] - USD ($)	Sep. 30, 2024	Aug. 02, 2024	Aug. 01, 2024	Jun. 30, 2024	Oct. 23, 2023	Sep. 06, 2023	Aug. 14, 2023	Jun. 30, 2023	May 01, 2023	Aug. 11, 2022
Principal amount of promissory notes payable	$ 4,500,000	$ 4,500,000	$ 12,000,000	$ 12,000,000	$ 1,250,000	$ 1,750,000	$ 1,500,000	$ 5,500,000	$ 1,500,000	$ 5,000,000
Accrued interest	0
Less: unamortized debt issue costs	0
Less: unamortized debt discount	0
Notes payable, net	$ 4,500,000

Note 5 - Debt - Long-term Debt

Note 5 - Debt - Long-term Debt Expected to Mature (Details)	Sep. 30, 2024 USD ($)
2024	$ 639,792
2025	767,849
2026	1,214,904
2027	1,686,449
2028	1,539,525
Thereafter	0
Debt, Long-Term and Short-Term, Combined Amount	$ 5,848,519

Note 6 - Common Stock and Pre_2

Note 6 - Common Stock and Preferred Stock (Details Textual)						1 Months Ended	2 Months Ended	9 Months Ended		12 Months Ended			21 Months Ended
	Aug. 05, 2024 USD ($) $ / shares shares	Apr. 07, 2024 USD ($) shares	Mar. 28, 2024 USD ($) $ / shares shares	Dec. 30, 2022 USD ($) $ / shares shares	Oct. 22, 2021 shares	Nov. 16, 2021 shares	Feb. 28, 2023 USD ($) shares	Sep. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2023 USD ($)	Dec. 31, 2023 $ / shares shares	Dec. 31, 2022 shares	Dec. 31, 2021 USD ($) shares	Sep. 30, 2024 USD ($) $ / shares shares	Feb. 28, 2022 shares
Common Stock, Shares Authorized (in shares)								50,000,000		50,000,000			50,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares								$ 0.0001		$ 0.0001			$ 0.0001
Common Stock, Voting Rights, Vote Per Share								1					1
Dividends, Common Stock, Total | $													$ 0
Stock Issued During Period, Shares, New Issues (in shares)												5,524,534
Proceeds from Issuance or Sale of Equity | $	$ 21,600,000											$ 11,500,000
Payments of Stock Issuance Costs | $								$ 0	$ 144,231			$ 2,100,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)														769,146
Preferred Stock, Shares Issued (in shares)								0		0			0
Preferred Stock, Shares Outstanding (in shares)								0		0			0
Proceeds from Issuance or Sale of Equity, Gross | $	22,000,000
Derivative Liability | $								$ 0					$ 0
Series A Convertible Preferred Stock [Member]
Proceeds from Issuance or Sale of Equity | $	20,400,000
Payments of Stock Issuance Costs | $	$ 403,000
Preferred Stock, Shares Issued (in shares)								22,000		0			22,000
Preferred Stock, Shares Outstanding (in shares)	22,000							22,000		0			22,000
Preferred Stock, Convertible, Shares Issuable (in shares)	7,213,115
Percent of Conversion Shares Owned	20%
Borrowed Money | $	$ 10,000,000
Percent of Common Stock Issuable	10%
Percent of Voting Stock	50%
Conversion Debt into Equity [Member]
Debt Conversion, Original Debt, Amount | $			$ 2,800,000
Warrants in Connection With Unit Purchase Agreement [Member]
Number of Warrant Per Unit (in shares)			1	1
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares)				0.5
Warrants and Rights Outstanding | $			$ 2.1
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)		2,071,293
Warrants and Rights Outstanding, Term (Year)		5 years
Warrants in Connection With Unit Purchase Agreement [Member] | Measurement Input, Price Volatility [Member]
Percentage of FIFO Inventory			58%
Warrants in Connection With Unit Purchase Agreement [Member] | Measurement Input, Risk Free Interest Rate [Member]
Percentage of FIFO Inventory			4.21%
Warrants in Connection With Unit Purchase Agreement [Member] | Measurement Input, Expected Term [Member]
Warrants and Rights Outstanding, Measurement Input			5.5
Warrants in Connection With Unit Purchase Agreement [Member] | Measurement Input, Expected Dividend Rate [Member]
Percentage of FIFO Inventory			0%
Purchaser Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)														591,656
Placement Agent Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)														177,490
North Run Warrants [Member]
Payments of Stock Issuance Costs | $	$ 31,000
Warrants and Rights Outstanding | $	$ 5,780,955
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)	2,885,246
Warrants and Rights Outstanding, Term (Year)	5 years 6 months
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares	$ 3.05
North Run Warrants [Member] | Warrants Liability [Member]
Derivative Liability | $	$ 1,600,000
Initial Closing Offering [Member]
Stock Issued During Period, Shares, New Issues (in shares)						961,092
Unit Purchase Agreement in Private Placement Offering [Member]
Proceeds from Issuance or Sale of Equity | $		$ 5,100,000	$ 5,000,000	$ 5.1			$ 9,200,000
Payments of Stock Issuance Costs | $			$ 600,000	$ 700,200			$ 1,200,000
Stock Issued During the Period, Units, New Issues (in shares)		2,071,293	2,015,293	647,057			1,183,192
Number of Common Stock Per Unit (in shares)			1	1
Shares Issued, Price Per Share (in dollars per share) | $ / shares			$ 2.5	$ 7.8
Proceeds from Issuance or Sale of Equity, Net | $		$ 3,000,000	$ 3,000,000
Selling Stockholders on October 22, 2021 [Member]
Stock Issued During Period, Shares, New Issues (in shares)					4,021,774
Pre-merger Stockholders of Laffin Acquisition Corp [Member]
Stock Issued During Period, Shares, New Issues (in shares)												495,834
Salem Investment Partners V, LP [Member]
Stock Issued During Period, Shares, New Issues (in shares)										1,097,500	1,097,500

Note 7 - Share-based Compensa_3

Note 7 - Share-based Compensation (Details Textual) - USD ($)	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)							210,000	94,667
Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit (in dollars per share)				$ 4.2
Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit (in dollars per share)				$ 9.42
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate				0%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)	0	8,500	0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period (in shares)	67,380	2,950	0
Stock Issued During Period, Shares, New Issues (in shares)						5,524,534
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Settlement of Options for Shares (in shares)	119,711
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	$ 200,000			$ 200,000
Share-Based Payment Arrangement, Granted Award, Option, Cost Not yet Recognized, Amount	$ 200,000			$ 200,000
Share-Based Payment Arrangement, Granted Award, Cost Not yet Recognized, Period for Recognition (Year)				2 years
Share-Based Payment Arrangement, Expense				$ 1,244,589	$ 883,450
Share-Based Payment Arrangement, Expense, Tax Benefit				0
Share-Based Payment Arrangement, Amount Capitalized				$ 0
Share-Based Payment Arrangement, Option [Member]
Stock Issued During Period, Shares, New Issues (in shares)	187,091
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	114,764
Share-Based Payment Arrangement, Expense	$ 1,800,000
The 2021 Plan [Member]
Common Stock, Capital Shares Reserved for Future Issuance (in shares)	37,166			37,166
Common Stock, Capital Shares Reserved for Future Issuance, Increase as Percentage of Total Share Outstanding	5%			5%

Note 7 - Share-based Compensa_4

Note 7 - Share-based Compensation - Stock Option Activity (Details) - $ / shares	3 Months Ended			12 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Shares underlying outstanding awards (in shares)	576,298	570,748	570,748
Shares underlying outstanding awards, weighted average exercise price (in dollars per share)	$ 7.63	$ 7.67	$ 7.67
Shares underlying outstanding awards, weighted average remaining contractual term (Year)	6 years 5 months 26 days	5 years 6 months 14 days	5 years 8 months 23 days	5 years 11 months 23 days
Granted (in shares)	0	8,500	0
Granted, weighted average exercise price (in dollars per share)		$ 2.5	$ 0
Exercised (in shares)	67,380	2,950	0
Exercised, weighted average exercise price (in dollars per share)	$ 2.02	$ 2.03	$ 0
Cancelled/forfeited (in shares)	119,711	0	0
Forfeited, weighted average exercise price (in dollars per share)	$ 2.03		$ 0
Granted (in shares)	0	8,500	0
Forfeited, weighted average exercise price (in dollars per share)	$ 2.03		$ 0
Shares underlying outstanding awards (in shares)	389,207	576,298	570,748	570,748
Shares underlying outstanding awards at March 31, 2024 (in dollars per share)	$ 8.9	$ 7.63	$ 7.67	$ 7.67
Exercisable options (in shares)	337,521
Exercisable options, weighted average exercise price (in dollars per share)	$ 7.13
Exercisable options, weighted average remaining contractual term (Year)	5 years 10 months 28 days

Note 7 - Share-based Compensa_5

Note 7 - Share-based Compensation - Schedule of Restricted Stock Units (Details) - Restricted Stock Units (RSUs) [Member]	3 Months Ended
	Sep. 30, 2024 $ / shares shares
Outstanding, shares (in shares) | shares	588,746
Outstanding, weighted average fair value (in dollars per share) | $ / shares	$ 5.66
Granted (in shares) | shares	114,764
Granted (in dollars per share) | $ / shares	$ 2.5
Vested (in shares) | shares	(128,106)
Vested (in dollars per share) | $ / shares	$ 4.5
Cancelled/forfeited (in shares) | shares	0
Cancelled/forfeited (in dollars per share) | $ / shares
Outstanding, shares (in shares) | shares	575,404
Outstanding, weighted average fair value (in dollars per share) | $ / shares	$ 5.53

Note 7 - Share-based Compensa_6

Note 7 - Share-based Compensation - Stock-based Compensation Expense (Details) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Stock-based compensation expense	$ 1,244,589	$ 883,450
Cost of Sales [Member]
Stock-based compensation expense	79,630	54,328
Research and Development Expense [Member]
Stock-based compensation expense	400,107	198,689
Selling and Marketing Expense [Member]
Stock-based compensation expense	284,409	138,983
General and Administrative Expense [Member]
Stock-based compensation expense	$ 480,443	$ 491,450

Note 8 - Derivative Liabiliti_3

Note 8 - Derivative Liabilities (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2024	Feb. 28, 2022
Derivative Liability	$ 0
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)		769,146
Percent of Outstanding Common Shares	50%
Historical Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)	2,895,709

Note 8 - Derivative Liabiliti_4

Note 8 - Derivative Liabilities - Summary of Changes in Fair Value of Level 3 Liabilities Measured on a Recurring Basis (Details) - Fair Value, Recurring [Member] - Fair Value, Inputs, Level 3 [Member]	9 Months Ended
	Sep. 30, 2024 USD ($)
Beginning balance as of January 1, 2024	$ 158,000
Change in fair value of derivative liabilities	(158,000)
Ending balance on September 30, 2024	$ 0

Note 8 - Derivative Liabiliti_5

Note 8 - Derivative Liabilities - Fair Value Measurement Inputs and Valuation Techniques (Details)	Sep. 30, 2024
Historical Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]
Risk free interest rate	3.58
Historical Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]
Risk free interest rate	3.71
Historical Warrants [Member] | Measurement Input, Expected Term [Member] | Minimum [Member]
Risk free interest rate	2.57
Historical Warrants [Member] | Measurement Input, Expected Term [Member] | Maximum [Member]
Risk free interest rate	5.15
Historical Warrants [Member] | Measurement Input, Price Volatility [Member] | Minimum [Member]
Risk free interest rate	51.3
Historical Warrants [Member] | Measurement Input, Price Volatility [Member] | Maximum [Member]
Risk free interest rate	60.8
Historical Warrants [Member] | Measurement Input, Expected Dividend Rate [Member]
Risk free interest rate	0
North Run Warrants [Member] | Measurement Input, Expected Term [Member] | Minimum [Member]
Risk free interest rate	5.35

Note 8 - Derivative Liabiliti_6

Note 8 - Derivative Liabilities - Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - Warrant Liabilities [Member]	9 Months Ended
	Sep. 30, 2024 USD ($)
Beginning balance as of January 1, 2024	$ 0
Reclassification of Historical Warrants	2,759,514
Issuance of warrant liabilities	1,563,400
Change in fair value of derivative liabilities	2,623,608
Ending balance on September 30, 2024	$ 6,946,522

Note 9 - Commitments and Cont_3

Note 9 - Commitments and Contingencies (Details Textual) - USD ($) $ in Thousands	Jun. 28, 2023	Sep. 30, 2024	Dec. 31, 2023
Chief Executive Officer [Member]
Deferred Salary, Percentage of Salaries	68%
Chief Operating Officer [Member]
Deferred Salary, Percentage of Salaries	68%
Chief Financial Officer [Member]
Deferred Salary, Percentage of Salaries	52%
Chief Business Officer [Member]
Deferred Salary, Percentage of Salaries	25%
Executive Management Team [Member]
Deferred Salary, Percentage of Salaries	2,000%
Legal Claims [Member]
Loss Contingency Accrual		$ 0	$ 0
Indemnification Agreement [Member]
Loss Contingency Accrual		$ 0	$ 0

Note 9 - Commitments and Cont_4

Note 9 - Commitments and Contingencies - Balance Sheet Information Related to Right-of-use Assets and Liabilities (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Operating lease right-of-use assets	$ 9,627,914	$ 10,500,620
Current portion of operating lease liabilities	657,978	745,969
Noncurrent portion of operating lease liabilities	5,694,467	6,176,508
Total operating lease liabilities	6,352,445
Finance lease right-of-use assets	1,736,013
Current portion of finance lease liabilities	800,091	978,543
Noncurrent portion of finance lease liabilities	1,045,966	$ 1,593,979
Total finance lease liabilities	$ 1,846,057

Note 9 - Commitments and Cont_5

Note 9 - Commitments and Contingencies - Lease Cost (Details) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating lease cost	$ 1,414,790	$ 1,210,436
Amortization of lease assets	797,910	944,413
Interest on lease liabilities	125,419	198,778
Total finance lease costs	$ 923,329	$ 1,143,191

Note 9 - Commitments and Cont_6

Note 9 - Commitments and Contingencies - Other Supplemental Information Related to Leases (Details) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating leases (Year)	8 years 2 months 1 day
Finance leases (Year)	2 years 5 months 12 days
Operating leases	11.02%
Finance leases	7.74%
Operating cash flows from operating leases	$ 1,112,118
Operating cash flows from finance leases	124,106
Financing cash flows from finance leases	$ 726,519	$ 812,315

Note 9 - Commitments and Cont_7

Note 9 - Commitments and Contingencies - Future Minimum Payments (Details)	Sep. 30, 2024 USD ($)
Operating leases, 2024	$ 347,862	[1]
Operating leases, 2025	1,233,668
Operating leases, 2026	1,056,589
Operating leases, 2027	1,076,140
Operating leases, 2028	1,096,206
Operating leases, thereafter	4,890,149
Operating leases, total	9,700,614
Less present value adjustment, 2024	171,926	[1]
Less present value adjustment, 2025	635,214
Less present value adjustment, 2026	580,820
Less present value adjustment, 2027	524,555
Less present value adjustment, 2028	460,933
Less present value adjustment, thereafter	974,721
Less present value adjustment, total	3,348,169
Operating lease liabilities, 2024	175,936	[1]
Operating lease liabilities, 2025	598,454
Operating lease liabilities, 2026	475,769
Operating lease liabilities, 2027	551,585
Operating lease liabilities, 2028	635,273
Operating lease liabilities, thereafter	3,915,428
Operating lease liabilities, total	6,352,445
Finance leases, 2024	283,979	[1]
Finance leases, 2025	815,150
Finance leases, 2026	722,306
Finance leases, 2027	156,861
Finance leases, 2028	49,664
Finance leases, thereafter	10,702
Finance leases, total	2,038,662
Less interest, 2024	33,538	[1]
Less interest, 2025	97,612
Less interest, 2026	46,269
Less interest, 2027	11,256
Less interest, 2028	3,787
Less interest, thereafter	143
Less interest, total	192,605
Finance lease liabilities, 2024	250,441	[1]
Finance lease liabilities, 2025	717,538
Finance lease liabilities, 2026	676,037
Finance lease liabilities, 2027	145,605
Finance lease liabilities, 2028	45,877
Finance lease liabilities, thereafter	10,559
Finance lease liabilities, total	$ 1,846,057
[1]Amounts are for the remaining six months ending December 31, 2024.

Note 10 - Income Taxes (Details

Note 10 - Income Taxes (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Income Tax Expense (Benefit)			$ 0	$ 0
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21%	21%
Domestic Tax Jurisdiction [Member] | Internal Revenue Service (IRS) [Member]
Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration					$ 26,826,582
Domestic Tax Jurisdiction [Member] | Internal Revenue Service (IRS) [Member] | R&D Tax Credit Carryforward [Member]
Tax Credit Carryforward, Subject to Expiration					$ 858,020

Note 11 - Related Party Trans_2

Note 11 - Related Party Transactions (Details Textual) - shares	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2021
Stock Issued During Period, Shares, New Issues (in shares)		5,524,534
Private Placement Offering [Member]
Stock Issued During Period, Shares, New Issues (in shares)	612,473

Note 12 - Employee Benefit Pl_2

Note 12 - Employee Benefit Plan (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay			4%
Defined Contribution Plan, Cost	$ 83,589	$ 87,205